Drug Trial Radar · NCT00002523
Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed
Last checked: Nov 20, 2026Latest source record: Sep 2, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,011
Actual
Start
Apr 1993
Primary completion
Mar 2003
Study completion Jan 2016
Sponsor
- Lead sponsor
- European Organisation for Research and Treatment of Cancer - EORTCResearch network
- Sponsor type
- Research network
- First posted
- Jan 27, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug, giving the drugs in different ways, and combining radiation therapy and surgery with chemotherapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare radiation therapy alone before surgery with radiation therapy plus fluorouracil and leucovorin before surgery, with and without fluorouracil and leucovorin after surgery in patients with rectal cancer that can be surgically removed.
Conditions
- Colorectal Cancer
Interventions
fluorouracilDrug
leucovorin calciumDrug
conventional surgeryProcedure
radiation therapyRadiation
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
35 sites in 10 countries. Site status is shown where the registry gives one.
Institut Jules Bordet
Brussels, Belgium
Hopital Universitaire Erasme
Brussels, Belgium
Hopital Civil de Charleroi
Charleroi, Belgium
Centre Hospitalier Universitaire de Tivoli
La Louvière, Belgium
Clinique Sainte Elisabeth
Namur, Belgium
Centre Paul Papin
Angers, France
Institut Sainte Catherine
Avignon, France
Centre Hospitalier General
Belfort, France
CHR de Besancon - Hopital Jean Minjoz
Besançon, France
C.H.U. de Brest
Brest, France
Centre Hospitalier Universitaire Henri Mondor
Créteil, France
Centre de Lutte Contre le Cancer, Georges-Francois Leclerc
Dijon, France
CHR de Grenoble - La Tronche
Grenoble, France
Centre Oscar Lambret
Lille, France
Centre Hospital Regional Universitaire de Limoges
Limoges, France
Service Cancerologie Polyclinique Clairval
Marseille, France
CRLCC Nantes - Atlantique
Nantes-Saint Herblain, France
Clinique De Valdegour
Nîmes, France
Hopital Jean Bernard
Poitiers, France
Clinique Sainte Clotilde
Sainte Clotilde, France
Centre Paul Strauss
Strasbourg, France
Centre Hospitalier Universitaire Bretonneau de Tours
Tours, France
Centre Saint-Yves
Vannes, France
Krankenhaus des Kreises Hameln-Pyrmont
Hamelin, Germany
Rambam Medical Center
Haifa, Israel
University Medical Center Nijmegen
Nijmegen, Netherlands
Dr. Bernard Verbeeten Instituut
Tilburg, Netherlands
Medical University of Gdansk
Gdansk, Poland
Institute of Oncology and Radiology of Serbia
Belgrade, Serbia
Hospital General Universitari Vall d'Hebron
Barcelona, Spain
Institut Catala d'Oncologia - Hospital Duran i Reynals
Barcelona, Spain
Hospital General Gregorio Maranon
Madrid, Spain
Kantonsspital Basel
Basel, Switzerland
UniversitaetsSpital
Zurich, Switzerland
Dokuz Eylul University School of Medicine
Izmir, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.